Shares of Progyny (PGNY), a leading provider of fertility benefits solutions, surged 5.34% in after-hours trading on Friday, following the company's impressive fourth-quarter 2024 earnings report and optimistic guidance for continued growth.
The company reported a 10.6% year-over-year increase in revenue to $298.4 million for the quarter, surpassing analysts' expectations. Adjusted earnings per share (EPS) of $0.42 also significantly exceeded consensus estimates of $0.10, driven by operational efficiencies and higher gross profits.
Progyny's strong performance was fueled by several key factors, including the addition of over 80 new clients, expansion of service offerings in areas like maternity and menopause, and a 99% client retention rate reflecting high satisfaction. The company also continued to invest in digital assets and product development, further enhancing its comprehensive fertility solutions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。